en

PRODUCT DETAIL

BEKEMV 300 mg koncentrát na infúzny roztok

Code 3576E
MA number EU/1/23/1727/001
Product Form: con inf 1x30 ml/300 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AJ Complement inhibitors
L04AJ01 Eculizumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 19.04.2023
Validity: 19.04.2028
SmPC + PL: European Medicines Agency's database
Dokument: BEKEMV Karta pacienta.pdf  
Dokument: BEKEMV Priručka pre lekára.pdf  
Dokument: BEKEMV Priručka pre pacienta_rodiča.pdf  
Dokument: BEKEMV_Certifikát o očkovaní_profylaxii antibiotikami.pdf  
Safety feature Yes
Data update: 06.02.2024
eu-flag.png sk-flag.png